GxP Audit RemediationGxP Audit ServicesPharmacovigilance AuditCAPA RemediationQuality Compliance

GxP Audit Remediation Case Study

See how PVCON helped a pharmaceutical company strengthen GxP compliance after audit findings through root cause assessment, CAPA planning and quality improvements.

PVCON Team4 min read
Client
Pharmaceutical company
Focus
GxP audit remediation, CAPA management, quality improvement and compliance strengthening
Duration
16 weeks
GxP audit remediation process showing findings review, CAPA implementation and compliance improvement

Strengthening GxP Controls After Audit Findings

How PVCON helped a pharmaceutical company address audit findings, strengthen quality controls and improve GxP compliance readiness.

Audit Findings Revealed Process Weaknesses

A pharmaceutical company conducted a quality assessment across its GxP operations and identified several areas requiring improvement.

The findings did not indicate a failure of the overall system, but highlighted process weaknesses that could affect consistency, documentation practices and operational control.

Key observations included inconsistent procedural implementation, incomplete documentation practices and limited evidence demonstrating the effectiveness of corrective actions.

The company needed more than a response document.

It required a structured remediation approach that could identify root causes, define sustainable corrective and preventive actions (CAPAs) and strengthen the underlying quality framework.

PVCON supported the organisation through GxP audit services, helping translate audit observations into practical improvements.

From audit findings to continuous improvement: GxP audit findings move through root cause analysis, a CAPA tracker, and quality review and effectiveness checks to CAPA evidence and closure, with a continuous-learning loop back to the start

Moving From Findings Closure to Sustainable Improvement

PVCON reviewed the audit observations and supported the organisation in developing a structured remediation plan.

The focus was not only on closing individual findings but understanding why the weaknesses occurred and how controls could be strengthened to prevent recurrence.

The engagement included:

  • Audit finding assessment
  • Root cause analysis support
  • CAPA development and tracking
  • Procedure and process review
  • Quality documentation improvement
  • Effectiveness review support

The remediation approach aligned corrective actions with the organisation's operational processes, ensuring that improvements could be maintained beyond the immediate audit response.

The work also supported stronger pharmacovigilance quality management by improving documentation, accountability and control mechanisms.

What Needed to Be Strengthened

GxP AreaChallenge IdentifiedPVCON SupportOutcome
ProceduresExisting processes were not consistently implementedReviewed procedures and operational workflowsImproved process alignment
DocumentationSupporting records lacked consistent traceabilityStrengthened documentation practicesBetter audit evidence availability
CAPA ManagementActions focused on correction rather than preventionSupported root cause-based CAPA developmentMore sustainable remediation approach
Quality OversightLimited effectiveness monitoring after actionsEstablished follow-up review approachImproved control visibility
Compliance ReadinessTeams required clearer expectationsProvided quality improvement guidanceStronger GxP compliance framework

From audit findings to CAPA closure in five steps: an audit finding is observed, root cause analysis identifies the cause, a CAPA action plans corrective and preventive actions, CAPA verification confirms deliverables and effectiveness, and CAPA closure records the resolved finding

From Audit Findings to Stronger Quality Controls

Through the remediation programme, the organisation established a more structured approach to managing audit observations.

The focus shifted from addressing individual findings to strengthening the processes behind them.

The company improved:

  • Documentation consistency
  • CAPA management practices
  • Process ownership
  • Evidence availability
  • Quality oversight mechanisms

The outcome was a more controlled GxP environment with improved visibility into compliance activities and stronger preparedness for future regulatory interactions.

Building Compliance Systems That Remain Audit Ready

Closing an audit finding is only one part of quality improvement.

A sustainable GxP system requires organisations to understand why weaknesses occurred, implement effective controls and demonstrate that those controls continue to work.

For this pharmaceutical company, the remediation effort created a stronger foundation for maintaining compliance beyond the immediate audit response.

PVCON supports organisations through GxP audit programmes, including audit preparation, execution support, remediation planning and compliance improvement initiatives.

Need support with GxP audit remediation? Explore PVCON's GxP audit support or contact PVCON to discuss strengthening your quality systems.